EMOR OTC
Healixa Inc
1W: -4.2%
1M: +21.2%
3M: -36.2%
YTD: +283.0%
1Y: +283.0%
3Y: -84.7%
5Y: -91.1%
$0.04
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$599K
+6688.5% ▲
5Y CAGR: +145.4%
Gross Profit
$211K
+968.0% ▲
5Y CAGR: +211.1%
Operating Income
-$6M
-1044.6% ▼
Net Income
-$7M
-942.8% ▼
EPS (Diluted)
$-0.01
-987.5% ▼
EBITDA
-$6M
-1110.8% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Revenue | $118K | $59K | $0 | $9K | $599K |
| YoY Growth | +1653.9% | -49.6% | -100.0% | +0.0% | +6688.5% |
| Cost of Revenue | $173K | $109K | $23K | $33K | $388K |
| Gross Profit | -$55K | -$50K | -$23K | -$24K | $211K |
| Gross Margin | -46.6% | -83.3% | — | -275.3% | 35.2% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1M | $3M | $3M | $531K | $7M |
| Operating Expenses | $1M | $3M | $3M | $531K | $7M |
| Operating Income | -$1M | -$3M | -$3M | -$555K | -$6M |
| Operating Margin | -920.5% | -5170.8% | — | -6292.1% | -1060.9% |
| Interest Expense | $21K | $11K | $224K | $550K | $380K |
| Income Before Tax | -$1M | -$15M | -$3M | -$645K | -$7M |
| Tax Expense | $0 | $0 | $0 | $0 | $33 |
| Net Income | -$1M | -$15M | -$3M | -$645K | -$7M |
| Net Margin | -938.6% | -25329.4% | — | -7316.1% | -1123.8% |
| EPS (Diluted) | $-0.00 | $-0.02 | $-0.00 | $-0.00 | $-0.01 |
| EBITDA | -$997K | -$15M | -$3M | -$522K | -$6M |
| Shares Outstanding | 788M | 810M | 817M | 778M | 773M |